Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02840578 · ClinicalTrials.gov registry record
NK Cell Activity in Smokers Screened for Lung Cancer
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 242
- Enrollment target
NCT02840578 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 242 participants.
The verdict
NCT02840578 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 242 participants
- Enrollment target
Study Summary
Objectives: To examine whether NK cell activity associates with two confirmed risk factors: (1) presence of indeterminate lung nodule(s) and (2) smoking exposure after controlling for potential confounders, including age, gender, body mass index (BMI), personal history of any cancer, and family history of cancer. This project is aimed at measuring NK cell activity, which may eventually help in reducing false positive rates of LDCT screening, improve early detection of lung cancer, and assist in risk assessment in patients with lung cancer. The investigators hypothesize that measurement of NK cell activity may be a useful tool for assessing changes in immunosurveillance in patients with conditions or diseases where NK cell activity has been shown to be reduced, such as lung cancer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2016-12-16 |
| Est. Completion | 2018-03-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02840578
The ClinicalTrials.gov registry entry for NCT02840578 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02840578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02840578 about?
NCT02840578 is a clinical study titled "NK Cell Activity in Smokers Screened for Lung Cancer". Objectives: To examine whether NK cell activity associates with two confirmed risk factors: (1) presence of indeterminate lung nodule(s) and (2) smoking exposure after controlling for potential confounders, including age, gender, body mass index (BMI), personal history of any cancer, and family hist...
What is the current status of trial NCT02840578?
This trial is currently completed. The enrollment target is 242 participants. The study started on 2016-12-16. Estimated completion is 2018-03-05.
Who is sponsoring clinical trial NCT02840578?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.